Role of reflexology and antiepileptic drugs in managing intractable epilepsy - A randomized controlled trial

Forschende Komplementarmedizin

Volumn 20, Issue 2, 2013, Pages 104-111

  Dalal, Krishna ^a   Devarajan, Elanchezhiyan ^a   Pandey, Ravindra Mohan ^a   Subbiah, Vivekanandan ^a   Tripathi, Manjari ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Complementary therapy; Indirect vagus nerve stimulation; Lower limb pain; Reflexology; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; FOLLOW UP; HUMAN; MALE; MASSAGE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; SEIZURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASSAGE; MIDDLE AGED; SEIZURES; YOUNG ADULT;

EID: 84877262334     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000350047     Document Type: Article

References (44)

1. Mbuba CK, Ngugi AK, Newton CR, et al.: The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008;49:1491-1503.
2. Marson AG, Al-Kharusi AM, Alwaidh M, et al.: The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: An unblinded randomised controlled trial. Lancet 2007;369:1000-1015. (Pubitemid 46436124)
3. Lieb JP, Engel J Jr, Babb TL: Interhemispheric propagation time of human hippocampal seizures. Relationship to surgical outcome. Epilepsia 1986; 27:286-293.
4. Rodriguez-Pinilia E, Arroyo I, Fondevilla J: Prenatal exposure to valproic acid during pregnancy and limb deficiencies: A case-control study. Am J Med Genet 2009;376-381.
5. Suzuki Y, Fukuda M, Tohyama M, et al.: Carbamazepine- induced drug-induced hypersensitivity syndrome in a 14-year-old Japanese boy. Epilepsia 2008;49:2118-2121.
6. Engel J Jr: A greater role for surgical treatment of epilepsy: why and when? Epilepsy Curr 2003;3: 37-40.
7. Amar AP, Apuzzo ML, Liu CY: Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the Vagus Nerve Stimulation Therapy Patient Outcome Registry. Neurosurgery 2004;55:1086-1093.
8. Vonck K, De Herdt V, Boon P: Vagal nerve stimulation - a 15-year survey of an established treatment modality in epilepsy surgery. Adv Tech Stand Neurosurg 2009:34:111-146.
9. Ramsay RE, Uthman BM, Augustinsson LE, et al.: Vagus nerve stimulation for treatment of partial seizures: 2. safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994;35:627-636. (Pubitemid 24217766)
10. Bliss J, Bliss G: How does reflexology work? Theories on why it does work. Reflexology Association of California, 2000. www.reflexcal.org/article4. html.
11. Mackereth P, Dryden SL, Frankel B: Reflexology: recent research approaches. Complement Ther Nurs Midwifery 2000;6:66-71.
12. Hughes CM, Krirsnakriengkrai S, Kumar S, et al.: The effect of reflexology on the autonomic nervous system in healthy adults: A feasibility study. Altern Ther Health Med 2011;17:32-37.
13. Hodgson H: Does reflexology impact on cancer patient's quality of life? Nurs Stand 2000;14:33-38.
14. Stephenson NL, Weinrich SP, Tavakoli AS: The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum 2000;27:67-72.
15. Mahboubeh V, Elaheh B, Reza H, et al.: Comparing the effects of reflexology methods and ibuprofen administration on dysmenorrhea in female students of Isfahan University of Medical Sciences. Iran J Nurs Midwifery Res 2010;15(suppl 1):371- 378.
16. Kim YH, Cho SH: The effect of foot reflexology on premenstrual syndrome and dysmenorrhea in female college students. Korean J Women Health Nurs 2002;8:212-221.
17. Zaccara G, Diego F, Perucca E: Critical review idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-1244. (Pubitemid 47063067)
18. Cynthia LH, David AM, Blagovest N, et al.: The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav 2007;11:208-211.
19. Bahl IP: Listen to Your Feet. New Delhi, Hind Pocket Books, 2005.
20. Tiran D, Harry C: The physiological basis of reflexology and its use as a potential diagnostic tool. Complement Ther Clin Pract 2005;11:58-64. (Pubitemid 40637260)
21. Shwartz M, Saitz R, Mulvey K, et al.: The value of acupuncture detoxification programs in a substance abuse treatment system. J Substance Abuse Treatment 1999;17:305-312. (Pubitemid 29528365)
22. Ding Li: Acupuncture Meridian Therapy and Acupuncture Points (translated by You Benlin and Wang Zhaorong). Beijing, Foreign Language Press, 1991.
23. Sakas DE, Korfias S, Nicholson CL, Panourias IG, Georgakoulias N, Gatzonis S, Jenkins A: Vagus nerve stimulation for intractable epilepsy: outcome in two series combining 90 patients. Acta Neurochir Suppl 2007:97:287-291.
24. Ramani R: Vagus nerve stimulation therapy for seizures: J Neurosurg Anesthesiol 2008;20:29-35. (Pubitemid 351628036)
25. Sinha S, Siddiqui KA: Definition of intractable epilepsy. Neurosciences (Riyadh) 2011;16:3-9.
26. Tomson T: Newer antiepileptic drugs and recent advances in drug therapy of epilepsy. Current Science 2002;82:698-706. (Pubitemid 135698164)
27. Wasterlain CG, Chen JWY: Mechanism and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 2008; 49(suppl 9):63-73.
28. Berg AT: Defining intractable epilepsy. Adv Neurol 2006;97:5-10.
29. Fitzerald WH, Bowers EF: Handbook of Zone Therapy (Cures for Common Ailments). Mumbai, D B Taraporevala Sons and Co. Pvt Ltd, 1986.
30. Theron DQ: The Solar Plexus or Abdominal Brain. New York, NY, Cosimo Inc, 2010.
31. Vicar JMC, Greenwood CR, Fewell F, et al.: Evaluation of anxiety, salivary cortisol and melatonin secretion following reflexology treatment: A pilot study in healthy individuals. Complement Ther Clin Pract 2007;13:137-145.
32. Evans PJ, Walker RF, et al.: Anticonvulsant therapy and cortisol elimination. Br J Clin Pharmacol 1985;20:129-132. (Pubitemid 15240604)
33. Marquardt H: Reflex zone therapy of the feet, a text for therapists. Northamptonshire, Thorsons Publishers Ltd., 1983.
34. Dougans I: Complete Illustrated Guide to Reflexology. New York, NY, Barnes and Noble Books, 1996.
35. Ingham ED, Byers DC: Original Works of Eunice D Ingham: Stories the Feet Can Tell Thru Reflexology/ Stories the Feet Have Told Thru Reflexology. Saint Petersburg, Ingham Publishing Inc., 1992.
36. Taisa FN, de Almeida BT, Lobo da Costa PH: Comparison of static footprints and pedobarography in obese and non-obese children. Foot Ankle Int 2008;29:1141-1144.
37. Vickrey BG, Perrine KP, Hays RD, et al.: Quality of life in epilepsy QOLIE-31, RAND, 1993.
38. Cramer JA, Perrine K, Devinsky O, et al.: Development and cross-cultural translation of a 31-item quality of Life questionnaire (QOLIE-31). Epilepsia 1998;81-88. (Pubitemid 28116846)
39. Elliott I, Kadis DS, Lach L, Olds J, McCleary L, Whiting S, Snyder T, Smith ML: Quality of life in young adults who underwent resective surgery for epilepsy in childhood. Epilepsia 2012;53:1-10.
40. Canuet L, Ishii R, Iwase M, et al.: Factors associated with impaired quality of life in younger and older adults with epilepsy. Epilepsy Res 2009;83: 58-65.
41. Williamson A, Hoggart B: Pain: A review of three commonly used pain rating scales. J Clin Nurs 2005;14:798-804. (Pubitemid 41018435)
42. Kumar N, Shekhar C, Kumar P, et al.: Kuppuswamy's socioeconomic status scale-updating for 2007. Ind J Ped 2007;74:1131-1132.
43. Berg AT, Berkovic SF, et al.: Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-685.
44. Vagus Nerve Stimulation Study Group: A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995;45:224-230.